U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607756) titled 'OCT-A Biomarkers for Cognitive Impairment in Patients With Chronic Atrial Fibrillation' on March 23.
Brief Summary: The OCTAF study is a monocentric, cross-sectional pilot study designed to investigate the relationship between retinal microvascular biomarkers and cognitive impairment in patients with atrial fibrillation (AF). Atrial fibrillation is a highly prevalent cardiac arrhythmia associated not only with stroke and cardiovascular complications but also with an increased risk of cognitive decline, even in the absence of overt cerebrovascular events. Current approaches to detect cognitive impairment are often time-consuming and r...